微芯生物 (688321.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

93.5x

Market Cap

CNY 11.47B

MomentumView details →

1D Return

−7.37%

YTD Return

—

RSI (14)

38.6

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

93.5x

Market Cap

CNY 11.47B

RSI (14)

38.6

MomentumView details →

1D Return

−7.37%

YTD Return

—

ProfitabilityView details →

Gross Margin

87.02%

Net Margin

9.79%

EBITDA Margin

12.01%

ROE (TTM)

3.81%

ROA (TTM)

2.15%

Asset Turnover

0.24x

GrowthView details →

Revenue YoY

+45.71%

EPS YoY

+184.24%

FCF YoY

+10.64%

Revenue CAGR 3Y

+19.75%

EPS CAGR 3Y

+42.72%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.10

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.28x

Current Ratio

2.56x

Quick Ratio

2.49x

Div Yield

0.23%

Div Rate

CNY 0.06

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

1.00B

Net Income (TTM)

98.39M

Op. CF (TTM)

101.33M

Latest newsMore news →

Chipscreen Biosciences reported its first-half 2026 results: net profit attributable to shareholders of 71.3806 million yuan, up 141.21% year-on-year.16d ago

Similar companies

Ab&B Bio Tech Co Ltd.02627.HK Consun Pharmaceutical Group Limited01681.HK 国药现代600420.SH 羚锐制药600285.SH 国邦医药605507.SH Sunshine Lake Pharma Co., Ltd.06887.HK Find similar companies →

Latest newsMore news →

Chipscreen Biosciences reported its first-half 2026 results: net profit attributable to shareholders of 71.3806 million yuan, up 141.21% year-on-year.16d ago